VC Deals

Relogix, an Ottawa-based workspace analytics platform and Internet-of-Things (IoT) sensor technology company, has closed its Series A financing, raising $4 million. The investors included BDC Capital’s Industrial, Clean and Energy Technology Venture Fund, Mistral Venture Partners and GroundBreak Ventures. Founded in 2010 by CEO Andrew Millar, Relogix provides its solutions to corporate real estate organizations.

Menlo Park, California-based Adicet Bio Inc, a biopharmaceutical company, has raised $80 million in Series B financing. The investors include aMoon2 Fund, Regeneron Pharmaceuticals, Inc., Johnson & Johnson Innovation – JJDC Inc, Samsung Venture Investment Corporation, OrbiMed, Novartis Venture Fund and Pontifax.

Seattle-based vaccines developer Icosavax has secured $52 million in Series A funding. Qiming Venture Partners USA led the round with participation from Adams Street Partners, Sanofi Ventures and NanoDimension.

Calgary-based Pason Systems Inc, a provider of specialized data management systems for drilling rigs, has agreed to acquire a minority stake in Intelligent Wellhead Systems Inc for $25 million. In addition to Pason's investment, Werklund Growth Fund LP has invested $10 million in IWS. Credit Suisse acted as financial adviser to WFO. Headquartered in Calgary, IWS is an oil and gas technology and service company.

Montreal-based Korbit Technologies, a education technology startup, has secured over US$2 million in seed funding. Khosla Ventures was the lead investor. Korbit is a spin-off from the Montreal-based Mila lab led by professor Yoshua Bengio.

New York City-based Riskcast Solutions, a brick city startup, has secured $600,000 in funding. Newark Venture Partners led the round with participation from Scopus Ventures.

Longliv Ventures is investing $5 million in DayTwo, a microbiome human discovery platform. DayTwo's other investors include Cathay Innovation and Samsung NEXT.

New York City-based Unqork, an enterprise software company, has raised $80 million in Series B funding. CapitalG led the round.

South San Francisco-based Tenaya Therapeutics Inc, a provider of curative therapies that target the underlying causes of heart disease, has secured $92 million in Series B financing. Casdin Capital led the round with participation from other investors that included GV and The Column Group.

AmacaThera, a Toronto-based developer of injectable hydrogel technology for medical applications, has secured US$3.6 million in seed funding. The investors were Sprout BioVentures/ Viva Biotech, Grey Sky Venture Partners and Toronto-based Lumira Ventures. AmacaThera is currently a resident company at the Johnson & Johnson Innovation – JLABS incubator.